VLC
AMGN icon

Van Leeuwen & Company’s Amgen AMGN Stock Holding History

Van Leeuwen & Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,938
Closed -$1.89M – 76
2019
Q1 		$1.89M Sell
9,938
-11,871
-54% -$2.27M 1.77% 22
2018
Q4 		$4.25M Sell
21,809
-105
-0.5% -$20.5K 4.24% 3
2018
Q3 		$4.54M Buy
+21,914
New +$4.32M 4.19% 4

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Van Leeuwen & Company's AMGN Position: Q2 2019 in Review

Van Leeuwen & Company sold out of Amgen (AMGN) in Q2 2019, closing a stake of 9,938 shares — an estimated $1.89M sold.

Van Leeuwen & Company first reported a position in AMGN in Q3 2018 and held it in 3 quarters. The position peaked at $4.54M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

  • Van Leeuwen & Company reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
  • Van Leeuwen & Company sold 9,938 Amgen shares in Q2 2019, an estimated $1.89M.
  • Van Leeuwen & Company first reported a position in Amgen in Q3 2018 and held it in 3 quarters.
  • Van Leeuwen & Company's Amgen position peaked at $4.54M in Q3 2018.
  • 1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Van Leeuwen & Company's 13F filing for Q2 2019, filed 31 Jul 2019.